Show simple item record

dc.contributor.authorHeatley, Heath
dc.contributor.authorBourdin, Arnoud
dc.contributor.authorMenzies-Gow, Andrew
dc.contributor.authorJackson, David J
dc.contributor.authorMaslova, Ekatarina
dc.contributor.authorChapaneri, Jatin
dc.contributor.authorSkinner, Derek
dc.contributor.authorCarter, Victoria
dc.contributor.authorShi Kai Chan, Jeffrey
dc.contributor.authorAriti, Cono
dc.contributor.authorHaughney, John
dc.contributor.authorPrice, David
dc.date.accessioned2023-01-04T11:48:01Z
dc.date.available2023-01-04T11:48:01Z
dc.date.issued2022-12-27
dc.identifier.citationHeatley , H , Bourdin , A , Menzies-Gow , A , Jackson , D J , Maslova , E , Chapaneri , J , Skinner , D , Carter , V , Shi Kai Chan , J , Ariti , C , Haughney , J & Price , D 2022 , ' An observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma ' , Thorax . https://doi.org/10.1136/thorax-2022-219642en
dc.identifier.issn0040-6376
dc.identifier.otherPURE: 223192769
dc.identifier.otherPURE UUID: 014678b1-e378-4dab-8f4d-3005995a495b
dc.identifier.otherPubMed: 36575040
dc.identifier.otherWOS: 000906028200001
dc.identifier.urihttps://hdl.handle.net/2164/19791
dc.descriptionFunding AstraZeneca funded the study (grant/award number: not applicable). AstraZeneca and OPRI had a role in study design, data collection, data analysis, data interpretation, and writing of the report. The corresponding author had full access to all the data and had final responsibility to submit for publication. Acknowledgements We would like to thank Sam Hijazi and Stefan Courtney of in Science Communications, Springer Healthcare Ltd, UK for providing medical writing support, which was funded by AstraZeneca in accordance with Good Publication Practice (GPP3) guidelines (http://www.ismpp.org/gpp3)en
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofThoraxen
dc.rights© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.en
dc.subjectAsthmaen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titleAn observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthmaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1136/thorax-2022-219642


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record